搜索结果: 1-15 共查到“医学 Discovery”相关记录48条 . 查询时间(0.077 秒)
近日,中南大学湘雅医院病理科陶永光研究员与肖德胜教授团队在国际期刊Cell Discovery(细胞发现,CD,IF=38.079)发表了题为“New mouse genetic model of breast cancer from IKKα defects in dendritic cells revealed by single-cell RNA sequencing(采用单细胞测序揭示树突...
《个性化药物: 新药研发的未来Personalized medicines, the future of drug discovery》
个性化药物 上海科学技术文献出版 上海药物研究所
2023/2/21
个性化药物: 新药研发的未来Personalized medicines, the future of drug discovery
上海市肿瘤研究所金浩杰研究员和Rene Bernards院士合作在Nature Reviews Drug Discovery杂志发表长篇综述文章:癌症联合靶向治疗的背景、优势与挑战(图)
金浩杰研究员 癌症 肿瘤药物 肿瘤细胞
2023/1/13
近日,上海市肿瘤研究所金浩杰研究员与René Bernards院士作为共同通讯作者在Nature Reviews Drug Discovery期刊上发表了长篇综述文章“Rational combinations of targeted cancer therapies: background, advances and challenges”,对癌症联合靶向治疗策略的背景、优势及面临的挑战进行全面...
上海交通大学医学院附属仁济医院肿瘤科、上海市肿瘤研究所国家重点实验室PI王理伟教授团队与仁济医院干细胞研究中心薛婧研究员团队合作在springer nature旗下著名期刊《cell discovery》(IF:10.849)在线发表了胰腺癌免疫治疗最新成果,课题组通过单细胞测序及相关临床研究首次发现了肿瘤相关成纤维细胞(CAF)的一种全新的亚群(命名为meCAF),其具有异常的糖代谢水平,并筛选...
Blood Cancer Discovery| 浙江大学医学院那仁满都拉/许志宏联合团队提出热激特异性降解融合癌蛋白的新概念(图)
浙江大学医学院 Blood Cancer Discovery 那仁满都拉 许志宏 热疗 癌蛋白
2021/5/13
2021年5月11日,浙江大学医学院那仁满都拉教授团队和许志宏研究员团队在美国癌症协会(AACR)重磅打造的新期刊Blood Cancer Discovery上在线发表了研究论文Hyperthermia Selectively Destabilizes Fusion Oncoproteins (https://bloodcancerdiscov.aacrjournals.org/content/e...
NSF provides support for drug discovery platform for hard-to-treat cancers(图)
NSF provides support drug discovery platform hard-to-treat cancers
2020/5/7
A new round of support will help a Purdue University-affiliated startup further develop a platform designed to create drugs for people with hard-to-treat cancers.Akanocure Pharmaceuticals, Inc., ...
AI accelerating drug discovery to fight COVID-19(图)
AI accelerating drug discovery fight COVID-19
2020/4/28
Researchers are running a global race to discover a vaccine, drug or combination of treatments that can disrupt the SARS-CoV-2 virus, which causes the COVID-19 disease, and prevent widespread deaths.M...
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Structure Mpro SARS-CoV-2 discovery inhibitors
2020/4/9
A new coronavirus, known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the aetiological agent responsible for the 2019–2020 viral pneumonia outbreak of coronavirus disease 2019 (...
NSF-funded researchers have made a new discovery about how seemingly minor aspects of the internal structure of bone can be strengthened to withstand wear and tear, a finding that could help patients ...
中山大学孙逸仙纪念医院宋尔卫教授团队研究论文在Nature Reviews Drug Discovery发表:化敌为友——靶向肿瘤相关成纤维细胞(图)
中山大学孙逸仙纪念医院 宋尔卫 研究论文 靶向肿瘤 纤维细胞
2018/12/20
肿瘤相关成纤维细胞(CAFs)通常是肿瘤微环境中最丰富的间质细胞,在肿瘤进展过程起着重要的作用。这提示CAFs可能成为恶性肿瘤治疗的理想靶点。2018年11月23日,我校孙逸仙纪念医院宋尔卫教授团队在Nature Reviews Drug Discovery(IF=50.17)在线发表了题为“Turning foes to friends: targeting cancer-associated ...
暨南大学生物医学转化研究院尹芝南团队在Cell Discovery杂志刊出科研成果(图)
暨南大学生物医学转化研究院 尹芝南团队 Cell Discovery杂志 科研成果 流行病学
2017/6/21
2017年6月20日,我校生物医学转化研究院尹芝南教授课题组在Cell Discovery杂志在线刊出题为“Long-term consumption of caffeine-free high sucrose cola beverages aggravates the pathogenesis of EAE in mice”的研究论文,揭示了长期摄入无咖啡因型高糖可乐饮料对小鼠自身免疫性疾病的促...
The Gordon Research Seminar on Preclinical Form and Formulation for Drug Discovery
Drug Discovery Preclinical Form
2017/3/7
Applications for this meeting must be submitted by May 6, 2017. Please apply early, as some meetings become oversubscribed (full) before this deadline. If the meeting is oversubscribed, it will be sta...